Search results
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Motley Fool· 12 months agoNovavax (NASDAQ: NVAX) investors have been on edge ever since the company fell behind in the...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Novavax COVID vaccine, potential 4th option, approved by FDA panel
NY Daily News via AOL· 2 years agoThe Novavax vaccine was 90% effective in clinical trials, but those tests were done in early 2021,...
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon...
Fortune via Yahoo Finance· 2 years agoThe U.S. Food and Drug Administration (FDA) on Wednesday approved the COVID-19 vaccine from American...
Novavax (NVAX) Up 8% on FDA Nod for Updated COVID Booster Jab
Zacks via Yahoo Finance· 7 months agoNovavax's (NVAX) updated COVID vaccine is authorized under emergency use for individuals aged 12...
Is Novavax Stock A Buy After Winning A Key Designation From The World Health Organization?
Investor's Business Daily· 3 months agoNovavax stock remained bound under its key moving averages in January 2024 despite winning numerous...
Novavax Covid vaccine becomes fourth to receive FDA approval
The Independent via Yahoo News· 2 years agoThe Food and Drug Administration authorised the use of Novavax Covid-19 vaccine for adults on...
Novavax raises doubts about ability to remain in business, shares fall
Reuters via Yahoo Finance· 1 year agoNEW YORK (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to...
Novavax sinks after halving sales forecast on low vaccine demand, supply glut
Reuters via Yahoo News· 2 years agoNovavax Inc on Monday halved its full-year revenue forecast as it does not expect further sales of...